Skip to main content
. 2022 Apr 11;9:826729. doi: 10.3389/fcvm.2022.826729

FIGURE 3.

FIGURE 3

Anti-ApoB IgG plasma levels are increased in patients with hypertension and obesity. Anti-ApoB IgG plasma levels were quantified by ELISA and grouped according to (A) patient diagnosis or the presence of cardiometabolic risk factors (B–F). CAD, coronary artery disease; ACS, acute coronary syndrome; DM, diabetes mellitus; HTN, hypertension; MS, metabolic syndrome.